Risk Factors Associated With Reoperation and Mortality in 252 Patients After Aortic Valve Replacement for Congenitally Bicuspid Aortic Valve Disease Sorel Goland, MD, Lawrence S.C. Czer, MD, Michele A. De Robertis, RN, James Mirocha, MS, Robert M. Kass, MD, Gregory P. Fontana, MD, Wen Chang, MD, Alfredo Trento, MD The Annals of Thoracic Surgery Volume 83, Issue 3, Pages 931-937 (March 2007) DOI: 10.1016/j.athoracsur.2006.10.047 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival of 252 patients undergoing aortic valve replacement for bicuspid aortic valve disease by degree of ascending aorta (AA) dilatation. Summary table provides survival estimates (± standard deviation) at 5, 10, and 15 years, respectively. The Annals of Thoracic Surgery 2007 83, 931-937DOI: (10.1016/j.athoracsur.2006.10.047) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Survival by decade of aortic valve replacement of 252 patients with bicuspid aortic valve disease. Summary table provides survival estimates (± standard deviation) at 5, 10, and 15 years, respectively. The Annals of Thoracic Surgery 2007 83, 931-937DOI: (10.1016/j.athoracsur.2006.10.047) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Survival of 252 patients undergoing aortic valve replacement for bicuspid aortic valve disease by presence or absence of coronary artery disease (CAD). Summary table provides survival estimates (± standard deviation) at 5, 10, and 15 years, respectively. The Annals of Thoracic Surgery 2007 83, 931-937DOI: (10.1016/j.athoracsur.2006.10.047) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions